Daunorubicin Hydrochloride

CAS 23541-50-6 7 current records 4 historicalSmall Molecule

Who holds supplier records for Daunorubicin Hydrochloride? 7 organisations hold a current record for Daunorubicin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Japan (2), Netherlands (1) and Italy (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Daunorubicin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/daunorubicin-hydrochloride

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Daunorubicin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

China2Japan2Netherlands1Italy1Country not recorded for 1
  • DZD (Heze) Pharmaceutical Co., Ltd.
    Active DMF 31150 · latest filing Nov 2016
    ChinaCEP Company GMP cert on record
  • Meiji Seika Pharma Co., Ltd.
    Active DMF 13727 · latest filing Sept 1998
    JapanCEP
  • TAPI NL BV
    Active DMF 13786 · latest filing Sept 1998
    NetherlandsCEP
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Active DMF 13775 · latest filing Sept 1998
    ChinaCEP Company GMP cert on record
  • MICROBIOPHARM JAPAN CO LTD
    Active DMF 11879 · latest filing Feb 1996
    Japan Company GMP cert on record
  • OLON SPA
    Active DMF 30425 · latest filing Mar 2016
    Italy Company GMP cert on record
  • Shandong New Time Pharmaceutical Co Ltd
    Active DMF 38625 · latest filing Aug 2023
    Company GMP cert on record
Need Daunorubicin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Daunorubicin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2012-380 - Rev 03
Daunorubicin Hydrochloride
Jan 2026—
TAPI NL B.V. AmsterdamNL
CEP 2001-284 - Rev 04
Daunorubicin Hydrochloride
Jul 2025—
DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze CityCN
R1-CEP 2016-253 - Rev 01
Daunorubicin Hydrochloride
Feb 2023—
MEIJI SEIKA PHARMA CO., LTD. TokyoJP
R1-CEP 2003-061 - Rev 02
Daunorubicin Hydrochloride
Jan 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Daunorubicin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • France · Inactive DMF 17218 · filed Mar 2004
  • RHONE POULENC RORER PHARMACEUTICALS INC
    Inactive DMF 13503 · filed Sept 1998
  • HAIMEN PHARM FACTORY
    Inactive DMF 8829 · filed Nov 1990
  • RHODIA INC
    Inactive DMF 2155 · filed Sept 1973

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Daunorubicin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1563).

Chemical identity

IUPAC name
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
Canonical SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl
InChIKey
GUGHGUXZJWAIAS-QQYBVWGSSA-N
Synonyms
Cerubidine, Daunorubicin (as hydrochloride), Daunorubicin hcl, Daunorubicin hydrochloride, FI 6339 [AS THE BASE], FI 6339 HYDROCHLORIDE, FI-6339 HYDROCHLORIDE, NDC 0082-4155, NDC-0082-4155, NSC-82151, RP 13057 [AS THE BASE), RP 13057 HYDROCHLORIDE

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anthracycline Topoisomerase Inhibitor
Mechanism of action
Topoisomerase Inhibitors
Chemical structure
Anthracyclines

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Daunorubicin Hydrochloride?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Daunorubicin Hydrochloride: DZD (Heze) Pharmaceutical Co., Ltd. (China), Meiji Seika Pharma Co., Ltd. (Japan), TAPI NL BV (Netherlands), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), MICROBIOPHARM JAPAN CO LTD (Japan), OLON SPA (Italy) and Shandong New Time Pharmaceutical Co Ltd. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Daunorubicin Hydrochloride Drug Master Files are active?

DZD (Heze) Pharmaceutical Co., Ltd. (DMF 31150), Meiji Seika Pharma Co., Ltd. (DMF 13727), TAPI NL BV (DMF 13786), Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 13775), MICROBIOPHARM JAPAN CO LTD (DMF 11879), OLON SPA (DMF 30425) and Shandong New Time Pharmaceutical Co Ltd (DMF 38625). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Daunorubicin Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Daunorubicin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Daunorubicin Hydrochloride have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Daunorubicin Hydrochloride on the EDQM register, including ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou City (CN), TAPI NL B.V. Amsterdam (NL), DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City (CN) and MEIJI SEIKA PHARMA CO., LTD. Tokyo (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Daunorubicin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Daunorubicin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.